Designer Bioscience Limited Filleted Accounts Cover
Designer Bioscience Limited
Company No. 06766447
Unaudited Accounts
31 July 2024
Designer Bioscience Limited Directors Report Registrar
The Director presents his report and accounts for the period ended 31 July 2024.
Principal activities
The principal activity of the company during the period under review was research and experimental development on biotechnology.
Director
The Director who served during the period was as follows:
X. Su
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board
........................................................................................................
M. Dong
Company Secretary
27 August 2024
Designer Bioscience Limited Balance Sheet Registrar
at
31 July 2024
Company No.
06766447
2024
2023
£
£
Fixed assets
202285
Current assets
392,742
Creditors: Amounts falling due within one year
(16,088)
(15,843)
Net current liabilities
(16,049)
(13,101)
Total assets less current liabilities
(15,847)
(12,816)
Accruals and deferred income
-
(550)
(15,847)
(13,366)
Capital and reserves
(15,847)
(13,366)
NOTES TO THE ACCOUNTS
1
Basis of preparation
These accounts have been prepared in accordance with the micro-entity provisions of the small companies regime.
2
Employees
2024
2023
Number
Number
The average monthly number of employees (including directors) during the period:
1
1
3
General information
Designer Bioscience Limited is a private company limited by shares and incorporated in England and Wales.
Its registered number is:
06766447
Its registered office is:
St John's Innovation Centre
Cowley Road
Cambridge
Cambridgeshire
CB4 0WS
For the period ended 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A) of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
The accounts were approved by the board of directors on 27 August 2024 and signed on its behalf by:
X. Su - Director
Designer Bioscience Limited0676644731 July 202401 January 2024false27 August 2024BTCSoftware AP Solution 2024 11.1.0111.1.01The principal activity of the company during the period under review was research and experimental development on biotechnology. 067664472024-01-012024-07-31067664472024-07-31067664472023-12-3106766447core:WithinOneYear2024-07-3106766447core:WithinOneYear2023-12-31067664472023-01-012023-12-3106766447countries:UnitedKingdom2024-01-012024-07-3106766447bus:RegisteredOffice2024-01-012024-07-31067664472024-01-0106766447bus:Micro-entities2024-01-012024-07-3106766447bus:FullAccounts2024-01-012024-07-3106766447bus:AuditExempt-NoAccountantsReport2024-01-012024-07-3106766447bus:Director12024-01-012024-07-3106766447bus:PrivateLimitedCompanyLtd2024-01-012024-07-31iso4217:GBPxbrli:pure